BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 7125859)

  • 21. [Endocrine therapy only in hormone-receptor-positive breast neoplasms].
    Bohnet HG; Weber H
    Med Klin; 1980 Nov; 75(23):818-22. PubMed ID: 6255300
    [No Abstract]   [Full Text] [Related]  

  • 22. [Current status in the treatment of breast cancer. I. Endocrine management--change of concepts and outlook for the future (author's transl)].
    Jehn U; Sauer H; Wilmanns W
    Klin Wochenschr; 1979 Sep; 57(18):913-20. PubMed ID: 388054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer of the breast: the past decade (second of two parts).
    Henderson IC; Canellos GP
    N Engl J Med; 1980 Jan; 302(2):78-90. PubMed ID: 7350436
    [No Abstract]   [Full Text] [Related]  

  • 24. [Endocrine therapy in breast carcinoma].
    Dogliotti L; Maschietto M; Ortega C
    Minerva Chir; 1988 Sep; 43(18 Suppl):63-6. PubMed ID: 3067123
    [No Abstract]   [Full Text] [Related]  

  • 25. Responsiveness to endocrine manipulations in breast cancer after "prophylactic" castration.
    Kaufman R; Salem P; Wittes RE
    J Surg Oncol; 1977; 9(1):39-43. PubMed ID: 839796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Chemo-hormonal therapy of carcinoma of the breast].
    Vertova F; Calza A
    Radiol Med; 1970 Nov; 56(11):1067-79. PubMed ID: 4941205
    [No Abstract]   [Full Text] [Related]  

  • 27. [The determination of receptors for estradiol in breast carcinomas and the possibilities of endocrine therapy].
    Aimone V; Campagnoli C; Fumero S; Perona M; Zanolo G
    Minerva Ginecol; 1975 Jul; 27(7):493-504. PubMed ID: 174031
    [No Abstract]   [Full Text] [Related]  

  • 28. [Ablative endocrine treatment of advanced or metastasizing breast cancer. Criteria of patient selection].
    Bocci A; Campagnoli C
    Minerva Chir; 1976 Nov; 31(22):1371-6. PubMed ID: 1012556
    [No Abstract]   [Full Text] [Related]  

  • 29. Palliative therapy for metastatic breast cancer.
    Pigott JD
    Postgrad Med; 1980 Mar; 67(3):165-7, 170-2, 174-5 passim. PubMed ID: 6153468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reliability of estrogen receptors in predicting hormonal responsiveness in treatment of metastatic breast cancer.
    Valenstein SL; Voigt W; Vogel CL; Thomsen S; Temple W
    J Fla Med Assoc; 1979 Nov; 66(11):1144-8. PubMed ID: 501325
    [No Abstract]   [Full Text] [Related]  

  • 31. The management of advanced breast cancer.
    Baum M
    Br J Hosp Med; 1980 Jan; 23(1):32, 35, 37-9. PubMed ID: 6153539
    [No Abstract]   [Full Text] [Related]  

  • 32. Estrogen receptor status in breast cancer.
    Wright CJ
    Can J Surg; 1980 Jul; 23(4):316-7. PubMed ID: 7417890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Content of epidermal growth factor receptor in metastatic breast cancer: its role in endocrine sensitivity prediction.
    Nesković-Konstantinović ZB; Nikolić-Vukosavljević DB; Branković-Magić MV; Mitrovic LB; Spuzić I
    Neoplasma; 2000; 47(2):107-13. PubMed ID: 10985476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [New data on relations between residual hormonal modulability and medical treatment of breast adenocarcinoma].
    Prodi G; Lollini PL; Nicoletti G
    Minerva Med; 1984 Feb; 75(6):219-21. PubMed ID: 6709205
    [No Abstract]   [Full Text] [Related]  

  • 35. HER-2 expression and response to tamoxifen in estrogen receptor-positive breast cancer: a Southwest Oncology Group Study.
    Elledge RM; Green S; Ciocca D; Pugh R; Allred DC; Clark GM; Hill J; Ravdin P; O'Sullivan J; Martino S; Osborne CK
    Clin Cancer Res; 1998 Jan; 4(1):7-12. PubMed ID: 9516946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Estrogen receptors in breast cancers and endocrine therapy].
    Maass H; Trams G; Nowakowski H
    Strahlentherapie; 1974 Apr; 147(4):381-7. PubMed ID: 4369557
    [No Abstract]   [Full Text] [Related]  

  • 37. Reliability of estrogen receptors in predicting response to antiestrogens.
    Valavaara R
    Oncology (Williston Park); 1997 May; 11(5 Suppl 4):14-8. PubMed ID: 9165501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rational approaches to the hormonal treatment of breast cancer.
    Allegra JC
    Semin Oncol; 1983 Dec; 10(4 Suppl 4):25-8. PubMed ID: 6669986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endocrine management of breast cancer.
    Schneider PG; Jackisch C; Brandt B
    Int J Fertil Menopausal Stud; 1994; 39 Suppl 2():115-27. PubMed ID: 7874188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High risk breast cancer: long-term surgical adjuvant therapy based on predictive tests - preliminary report.
    Peek U; Tanneberger S; Heise E; Görlich M; Nissen E; Marx G; Projan A; Winkler R; Kunde D; Bodek B
    Arch Geschwulstforsch; 1981; 51(1):139-51. PubMed ID: 7259436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.